Revenio Group Oyj
REG1V
Rank in Stocks
#14806
Revenio Group Oyj, provides ophthalmological devices and software solutions for... Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used for measuring IOP on animal patients by general veterinary practitioners, veterinary ophthalmologists and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON, a device with confocal retinal imaging; iCare DRSplus, a device for pupil imaging; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. In addition, the company offers iCare ILLUME, a screening software that helps to detect the early signs of diabetic retinopathy, age-related macular degeneration, and glaucoma using artificial intelligence; iCare CLINIC cloud software to store long-term IOP data; and Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.
Share Price
$10.24
Last synced: 2026-11-13
Market Cap
$298.05M
Change (1 day)
2.59%
Change (1 year)
-61.70%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Revenio Group Oyj (REG1V)
Category
Healthcare
Operating Margin for Revenio Group Oyj (REG1V)
Operating Margin as of November 2026 TTM: 14.15%
According to Revenio Group Oyj's latest financial reports, its current operating margin (TTM) is 14.15%. At the end of 2025 the company had an operating margin of 23.15%.
Operating Margin history for Revenio Group Oyj from 2002 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 14.15% | -38.88% |
| 2025 | 23.15% | -4.34% |
| 2024 | 24.20% | -11.29% |
| 2023 | 27.28% | -10.88% |
| 2022 | 30.61% | 9.09% |
| 2021 | 28.06% | 0.04% |
| 2020 | 28.05% | 10.22% |
| 2019 | 25.45% | -23.55% |
| 2018 | 33.29% | 9.83% |
| 2017 | 30.31% | 0.63% |
| 2016 | 30.12% | 5.91% |
| 2015 | 28.44% | 3.31% |
| 2014 | 27.53% | 26.63% |
| 2013 | 21.74% | 12.00% |
| 2012 | 19.41% | 88.81% |
| 2011 | 10.28% | -578.14% |
| 2010 | -2.15% | 1.42% |
| 2009 | -2.12% | -125.36% |
| 2008 | 8.36% | 2.45% |
| 2005 | 8.16% | -262.23% |
| 2004 | -5.03% | -54.44% |
| 2003 | -11.04% | -29.55% |
| 2002 | -15.67% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -98.92% |
US
|
|
| 18.08% | -98.72% |
IE
|
|
| 21.25% | -98.50% |
US
|
|
| 21.05% | -98.51% |
US
|
|
| 28.09% | -98.01% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Revenio Group Oyj's operating margin
What is Revenio Group Oyj's operating margin?
Revenio Group Oyj's operating margin is 14.15%, as of Nov 2026.
What was Revenio Group Oyj's operating margin in 2025?
In 2025, Revenio Group Oyj's operating margin was 23.15%, compared with 24.20% in 2024.
How has Revenio Group Oyj's operating margin changed since 2020?
From 2020 to 2025, Revenio Group Oyj's operating margin was highest in 2022 (30.61%) and lowest in 2025 (23.15%).
How does Revenio Group Oyj's operating margin compare with similar companies?
Revenio Group Oyj's operating margin (14.15%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.